Delivery Order SPE2DB24D1007-SPE2DB25FB5QL
Award Date 9/18/25
Potential Completion Date 10/9/25
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $12,467.00 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body 2.4ML injectable medication, with an ultimate completion date of December 18, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $11,830.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injectable medication on September 11, 2025. This non-set-aside contract is scheduled for completion by October 2, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant used to treat moderate to severe plaque psoriasis and other inflammatory conditions,...
- The Defense Logistics Agency awarded a $11,830 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectable medication in 2.4 mL quantities. The award, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, was made without a set-aside designation through competitive procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a $11,830 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injector units on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a prescription biologic medication used to treat autoimmune conditions, and...
- The Defense Logistics Agency awarded a $25,209.26 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injectors on April 29, 2025, with a completion date of May 20, 2025. This firm fixed price, non-set-aside contract was issued under a competitive procurement process and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic treatment used for dermatological conditions, representing part of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injection units, valued at $11.8K with a firm fixed price structure. This is a non-set-aside competitive award issued on August 13, 2025, with an ultimate completion date of September 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. SKYRIZI is a prescription biologic medication indicated for the treatment of...
- The Defense Logistics Agency awarded a $12,467 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body injectors on October 24, 2025. This competitively awarded, firm fixed-price contract, which carries no set-aside designation, is scheduled for completion by November 17, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. SKYRIZI is a specialized biologic medication indicated for inflammatory skin conditions,...
- The Defense Logistics Agency awarded a $12,467 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body auto-injectors on December 9, 2025. This competitively awarded, non-set-aside contract is scheduled for completion by December 31, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant medication used to treat inflammatory conditions such as psoriasis and Crohn's...
- The Defense Logistics Agency awarded a delivery order valued at $12,239.38 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 600 mg/10 mL vials on September 24, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 16, 2025, with performance at the vendor's Conshohocken, Pennsylvania facility. SKYRIZI is a biologic immunosuppressant used to treat various inflammatory conditions, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injectable medication. This firm fixed price delivery order, issued on July 16, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive award under an existing contract vehicle. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant...